Cargando…
SARS-CoV-2 main protease targeting potent fluorescent inhibitors: Repurposing thioxanthones
The coronavirus disease, COVID-19, is the major focus of the whole world due to insufficient treatment options. It has spread all around the world and is responsible for the death of numerous human beings. The future consequences for the disease survivors are still unknown. Hence, all contributions...
Autores principales: | BATIBAY, Gönül S., METİN, Eyüp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388053/ https://www.ncbi.nlm.nih.gov/pubmed/37528926 http://dx.doi.org/10.55730/1300-0527.3541 |
Ejemplares similares
-
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022) -
From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease †
por: Göhl, Matthias, et al.
Publicado: (2022) -
Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022) -
Diastereomeric
Resolution Yields Highly Potent Inhibitor
of SARS-CoV-2 Main Protease
por: Cooper, Mark S., et al.
Publicado: (2022) -
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)